Some individuals may experience mild reactions such as digestive discomfort or localized irritation at the injection site
Collectively, these data highlight the importance of integrating metabolic health into early therapeutic strategies for PsA, particularly in individuals at high risk of disease progression or in those presenting with subclinical musculoskeletal involvement
Neurochem Res 40:25272543 Higgins RD, Raju T, Edwards AD, Azzopardi DV, Bose CL, Clark RH, Ferriero DM, Guillet R, Gunn AJ, Hagberg H, Hirtz D, Inder TE, Jacobs SE, Jenkins D, Juul S, Laptook AR, Lucey JF, Maze M, Palmer C, Papile L, Pfister RH, Robertson NJ, Rutherford M, Shankaran S, Silverstein FS, Soll RF, Thoresen M, Walsh WF (2011) Hypothermia and other treatment options for neonatal encephalopathy: an executive summary of the Eunice Kennedy Shriver NICHD workshop
Lipid peroxidation and free radical scavengers in Alzheimer's disease
10.1093/jxb/erl249 85 KuzniakE.SklodowskaM